Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Southern

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2015
TRPV4 Mechanosensitive Ion Channel Regulates Lipopolysaccharide-Stimulated Macrophage PhagocytosisRachel G Scheraga, Susamma Abraham, Kathryn A Niese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2020
TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway SwitchingRachel G Scheraga, Susamma Abraham, Lisa M Grove, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Inhibition of De Novo Autoantibody Production Attenuates Chronic Antibody-Mediated Rejection of Kidney Allografts Despite Maintenance of High Donor-Specific Antibody TitersYosuke Mitsui, Karen S Keslar, Michael Nicosia, et al.
The Journal of Biological Chemistry|January 9, 2026
Transient Receptor Potential Vanilloid 4 in Macrophages Mediates TGF-β Activation to Drive Myofibroblast Differentiation and Pulmonary FibrosisLisa M Grove, Caitlin Snyder, Adam M Boulton, et al.
Respiratory Research|October 22, 2025
Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosisAravind A Menon, Benedikt Gansen, Hillary Mulder, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|April 15, 2021
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with NintedanibFranck Rahaghi, John A Belperio, John Fitzgerald, et al.
The Journal of Biological Chemistry|March 20, 2014
Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblastsLisa M Grove, Brian D Southern, Tong H Jin, et al.
The American Journal of Pathology|March 19, 2013
FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosisQiang Ding, Guo-Qiang Cai, Meng Hu, et al.
The Journal of Biological Chemistry|January 15, 2016
Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast PhenotypeBrian D Southern, Lisa M Grove, Shaik O Rahaman, et al.
American Heart Journal|April 3, 2020
Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?Manuel L Ribeiro Neto, Christine Jellis, Rory Hachamovitch, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2015
TRPV4 Mechanosensitive Ion Channel Regulates Lipopolysaccharide-Stimulated Macrophage PhagocytosisRachel G Scheraga, Susamma Abraham, Kathryn A Niese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2020
TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway SwitchingRachel G Scheraga, Susamma Abraham, Lisa M Grove, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Inhibition of De Novo Autoantibody Production Attenuates Chronic Antibody-Mediated Rejection of Kidney Allografts Despite Maintenance of High Donor-Specific Antibody TitersYosuke Mitsui, Karen S Keslar, Michael Nicosia, et al.
The Journal of Biological Chemistry|January 9, 2026
Transient Receptor Potential Vanilloid 4 in Macrophages Mediates TGF-β Activation to Drive Myofibroblast Differentiation and Pulmonary FibrosisLisa M Grove, Caitlin Snyder, Adam M Boulton, et al.
Respiratory Research|October 22, 2025
Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosisAravind A Menon, Benedikt Gansen, Hillary Mulder, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|April 15, 2021
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with NintedanibFranck Rahaghi, John A Belperio, John Fitzgerald, et al.
The Journal of Biological Chemistry|March 20, 2014
Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblastsLisa M Grove, Brian D Southern, Tong H Jin, et al.
The American Journal of Pathology|March 19, 2013
FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosisQiang Ding, Guo-Qiang Cai, Meng Hu, et al.
The Journal of Biological Chemistry|January 15, 2016
Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast PhenotypeBrian D Southern, Lisa M Grove, Shaik O Rahaman, et al.
American Heart Journal|April 3, 2020
Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?Manuel L Ribeiro Neto, Christine Jellis, Rory Hachamovitch, et al.
Pageof 4